| Literature DB >> 30250407 |
Martina Pellegrini1, Debora Formisano2, Veronica Bucciarelli1, Margherita Schiavi3, Stefania Fugazzaro1, Stefania Costi4,5.
Abstract
INTRODUCTION: To determine effect size and feasibility of experimental occupational therapy (OT) intervention in addition to standard care in a population of complex patients undergoing rehabilitation in a hospital-home-based setting.Entities:
Mesh:
Year: 2018 PMID: 30250407 PMCID: PMC6140010 DOI: 10.1155/2018/3081094
Source DB: PubMed Journal: Occup Ther Int ISSN: 0966-7903 Impact factor: 1.448
Clinical outcome measures and study assessments.
| T0 | T1 | T2 | ||
|---|---|---|---|---|
| Comorbidities (CCI) | X | Randomization | ||
| Performance in carrying out occupational activities (COPM) | X | X | X | |
| Satisfaction in carrying out occupational activities (COPM) | X | X | X | |
| Mood disturbances (HADS) | X | X | X | |
| B-ADL (MBI) | X | X | X | |
| I-ADL (IADL) | X | X | X | |
| Reintegration to Normal Living Index (RNLI) | X | X | ||
| Quality of life (SF-12) | X | X |
PRM: physical and rehabilitation medicine; CCI: Charlson Comorbidity Index; COPM: Canadian Occupational Performance Measure; HADS: Hospital Anxiety and Depression Scale; B-ADL: basic activities of daily living; MBI: modified Barthel Index; I-ADL: instrumental activities of daily living; IADL: instrumental activities of daily living; RNLI: Reintegration to Normal Living Index; SF-12: Short Form-12.
Planning checklist of OT intervention for each goal set.
| Phase | Activity | Options | |
|---|---|---|---|
| A | Definition of the OT rehabilitative approach | Restorative | Compensative |
| B | Definition of treatment posology | Number of sessions | |
| Frequency of sessions | |||
| Duration of each session | |||
| C | Definition of any supports and/or facilitation strategies to be used during sessions (e.g., aids, caregivers, and facilities) | ||
| D | Definition of the intervention setting/s | ||
| E | Group sessions | Yes | No |
Figure 1CONSORT 2010 flow diagram of the study.
Baseline characteristics of the study participants.
| Characteristics | IG ( | CG ( |
|
|---|---|---|---|
| Age (mean ± SD) | 66.35 (±14.67) | 62.75 (±10.99) | 0.38a |
| Gender, F/M (%) | 8/12 (40/60%) | 9/11 (45/55%) | 0.74b |
| RCS-E (mean ± SD) | 10.75 (±0.96) | 10.75 (±0.91) | 1.00a |
| CCI (mean ± SD) | 5.20 (±2.41) | 5.15 (±2.18) | 0.94a |
| Main diagnosis of access for rehabilitation (%) | 0.853b | ||
| Acute polyneuropathy | 6 (30%) | 5 (25%) | |
| Stroke | 5 (25%) | 4 (20%) | |
| Cancer | 4 (20%) | 3 (15%) | |
| Hemiparesis due to acute neurological syndrome | 2 (10%) | 2 (10%) | |
| Lower limb amputation | 1 (5%) | 3 (15%) | |
| Orthopedic diseases or musculoskeletal trauma | 1 (5%) | 2 (10%) | |
| Paraplegia | 1 (5%) | 1 (5%) |
IG: intervention group; CG: control group; SD: standard deviation; aStudent's t-test; F/M: female versus male ratio; bPearson's chi-square test or Fisher's exact test; RCS-E: Rehabilitation Complexity Scale-Extended; CCI: Charlson Comorbidity Index.
Figure 2Distribution of relevant occupational activities chosen by participants in this study.
Between-group differences of average changes during the study course for the main clinical outcome measures.
| ΔIG (mean ± SD) | ΔCG (mean ± SD) |
| Mean difference (95% CI) | |
|---|---|---|---|---|
| COPM perf. | ||||
| T1-T0 | 3.18 ± 1.89 | 1.21 ± 1.13 | 0.001 | −1.97 (−3.03; −0.91) |
| T1-T2 | 1.98 ± 1.98 | 1.26 ± 2.16 | 0.336 | −0.72 (−2.22; 0.78) |
| T2-T0 | 5.62 ± 2.10 | 2.56 ± 1.89 | 0.001 | −3.06 (−4.50; −1.61) |
| COPM satisf. | ||||
| T1-T0 | 3.01 ± 2.25 | 1.26 ± 1.15 | 0.006 | −1.75 (−2.96; −0.53) |
| T1-T2 | 1.97 ± 2.53 | 1.35 ± 2.05 | 0.454 | −0.61 (−2.27; 1.04) |
| T2-T0 | 5.52 ± 2.10 | 2.70 ± 1.88 | 0.001 | −2.81 (−4.25; −1.37) |
| MBI | ||||
| T1-T0 | 41.77 ± 20.34 | 30.16 ± 22.37 | 0.113 | −11.61 (−26.10; 2.88) |
| T1-T2 | 6.00 ± 6.34 | 4.52 ± 10.98 | 0.652 | −1.47 (−8.06; 5.12) |
| T2-T0 | 49.33 ± 20.14 | 37.00 ± 18.58 | 0.082 | −12.33 (−26.31; 1.64) |
| IADL | ||||
| T1-T0 | −1.15 ± 0.81 | −0.51 ± 0.46 | 0.007 | 0.64 (0.18; 1.09) |
| T1-T2 | −0.55 ± 0.62 | −0.53 ± 0.79 | 0.938 | 0.02 (−0.50; 0.54) |
| T2-T0 | −1.83 ± 0.88 | −1.06 ± 0.78 | 0.014 | 0.76 (0.16; 1.36) |
| RNLI | ||||
| T2-T1 | 24.46 ± 20.28 | 10.47 ± 21.39 | 0.068 | −13.98 (−29.05; 1.07) |
Δ = within-group change; IG: intervention group; CG: control group; SD: standard deviation; CI: confidence interval; COPM: Canadian Occupational Performance Measure; perf.: performance; satisf.: satisfaction; MBI: modified Barthel Index; IADL: instrumental activities of daily living; RNLI: Reintegration to Normal Living Index.
Figure 3Proportion of patients whose gain in COPM performance score exceeded the minimal clinically important difference set for the COPM.
Figure 4Proportion of patients whose gain in COPM satisfaction score exceeded the minimal clinically important difference set for the COPM.
Between-group comparisons of average scores for all clinical outcome measures.
| T0 | T1 | T2 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| IG ( | CG ( |
| IG ( | CG ( |
| IG ( | CG ( |
| |
| COPM perf. (mean ± SD) | 1.73 ± 0.78 | 2.21 ± 0.81 | 0.064 | 4.89 ± 1.73 | 3.44 ± 1.41 | 0.009 | 7.28 ± 1.67 | 4.77 ± 1.89 | 0.001 |
| COPM satisf. (mean ± SD) | 1.86 ± 0.69 | 2.22 ± 1.05 | 0.21 | 4.86 ± 2.0 | 3.55 ± 1.44 | 0.031 | 7.33 ± 1.89 | 4.98 ± 1.81 | 0.001 |
| HADS anx. (mean ± SD) | 6.90 ± 3.74 | 6.80 ± 3.79 | 0.93 | 5.78 ± 3.93 | 5.56 ± 4.20 | 0.87 | 4.13 ± 3.29 | 6.77 ± 4.67 | 0.08 |
| HADS depr. (mean ± SD) | 7.40 ± 4.26 | 6.35 ± 3.94 | 0.42 | 6.44 ± 4.33 | 6.17 ± 4.20 | 0.85 | 5.53 ± 3.16 | 6.65 ± 5.04 | 0.47 |
| MBI (mean ± SD) | 37.85 ± 20.32 | 49.60 ± 25.11 | 0.11 | 77.11 ± 23.29 | 80.50 ± 20.17 | 0.64 | 88.00 ± 14.40 | 88.18 ± 13.20 | 0.97 |
| IADL (mean ± SD) | 5.09 ± 1.15 | 4.55 ± 1.12 | 0.14 | 3.99 ± 1.26 | 4.01 ± 0.97 | 0.95 | 2.98 ± 1.13 | 3.42 ± 1.06 | 0.26 |
| RNLI (mean ± SD) | 46.86 ± 17.11 | 46.81 ± 16.79 | 0.99 | 72.57 ± 15.56 | 58.11 ± 22.04 | 0.043 | |||
| SF-12 PCS (mean ± SD) | 32.80 ± 5.39 | 33.89 ± 7.89 | 0.63 | 34.84 ± 7.19 | 31.68 ± 7.49 | 0.23 | |||
| SF-12 MCS (mean ± SD) | 42.59 ± 11.05 | 43.21 ± 17.09 | 0.90 | 46.32 ± 11.87 | 42.90 ± 13.41 | 0.45 | |||
IG: intervention group; CG: control group; COPM: Canadian Occupational Performance Measure; perf.: performance; SD: standard deviation; satisf.: satisfaction; HADS: Hospital Anxiety and Depression Scale; anx.: anxiety; depr.: depression; MBI: modified Barthel Index; IADL: instrumental activities of daily living; RNLI: Reintegration to Normal Living Index; SF-12: Short Form-12; PCS: Physical Health Composite Score; MCS: Mental Health Composite Score.